| For: | Chen JW, Liu CY, Li S, Wu SW, Cai C, Lu MQ. Sepsis-associated liver injury: Mechanisms and potential therapeutic targets. World J Gastroenterol 2024; 30(42): 4518-4522 [PMID: 39563749 DOI: 10.3748/wjg.v30.i42.4518] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v30/i42/4518.htm |
| Number | Citing Articles |
| 1 |
Jianjun Wang, Yonghai Peng, Zhaohui Hu, Xi Chen, Sirui Chen, Pei Yang, Xintao Zeng, Decai Wang. Prognostic value of albumin-corrected anion gap in critically ill patients with sepsis-associated liver injury: a retrospective study. BMC Infectious Diseases 2025; 25(1) doi: 10.1186/s12879-025-11321-7
|
| 2 |
Yupeng Li, Junyi Fan, Kamiar Alaei, Maryam Pishgar. Development of Machine Learning Models to Predict 28-Day Mortality in Patients with Sepsis-Associated Liver Injury. BioMedInformatics 2026; 6(1): 4 doi: 10.3390/biomedinformatics6010004
|
| 3 |
Binglin Song, Ping Liu, Chun Liu, Kangrui Fu, Xiangde Zheng, Ying Liu. Development and validation of a predictive model for continuous renal replacement therapy in sepsis patients using the MIMIC-IV database. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-07647-6
|
| 4 |
Yuhan Liu, Yu Lei, Luorui Shang, Zhaomin Yu, Li Wang, Jiabin Zhou, Guangtao Pan. Protective effects of Dachengqi Decoction in sepsis-associated liver injury based on network pharmacology analysis and experimental validation. Journal of Ethnopharmacology 2025; 353: 120450 doi: 10.1016/j.jep.2025.120450
|
| 5 |
Jing Yan, Yifeng Pan, Zhu Liu, Yulin Chen, Kai Hu, Yuanyuan Liu, Guangyao Wang, Liqun Li, Sheng Xie. Modified Xuan-Bi-Qing-Ying decoction alleviates septic liver injury by regulating autophagy and apoptosis via HIF-1α signaling pathway. Tissue and Cell 2026; 99: 103299 doi: 10.1016/j.tice.2025.103299
|
| 6 |
Chen Ouyang, Yuxi Liu, Xin Li, Pengpeng Liu, Quanyan Liu. Association between intravenous magnesium sulfate and mortality in patients with sepsis-associated liver injury: a retrospective cohort study. Frontiers in Medicine 2026; 12 doi: 10.3389/fmed.2025.1679032
|
| 7 |
Zhen Yang, Xingyu Kao, Tianwei Zhu, Junna Lei, Na Huang, Jingli Chen, Mingfeng He, Qi Tang, Zhangrong Liang. Clinical efficacy and metabolomics profiling of dachaihu decoction for patients with septic liver injury: a randomized controlled trial. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1671732
|
| 8 |
Xinqi Xu, Tingyu Yang, Jiapan An, Bin Li, Zhimin Dou. Liver injury in sepsis: manifestations, mechanisms and emerging therapeutic strategies. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1575554
|
| 9 |
Eleni V. Geladari, Anastasia-Amalia C. Kalergi, Apostolos A. Evangelopoulos, Vasileios A. Sevastianos. Sepsis and the Liver. Diseases 2025; 13(12): 388 doi: 10.3390/diseases13120388
|
| 10 |
Kaina Zhang, Mengqing Liu, Yeqing Zheng, Zuozhong Gao, Ziwei Dong, Mengyao You, Yang Guo, Fanfan Liang, Zhenghang Zhao. TRIM16 mediates YAP1 K63-linked ubiquitination to alleviate sepsis-induced acute liver injury through YAP/Nrf2 axis in mice. Cell & Bioscience 2025; 16(1) doi: 10.1186/s13578-025-01517-4
|
| 11 |
Hilal Üstündağ, Songul Doganay. Septic Shock - From Pathophysiology to Patient Care. 2025; doi: 10.5772/intechopen.1009751
|
| 12 |
Yan Pan, Youting Xu, Ting Shui, Jiao Hong, Xuan Lu, Huilin Chen. Mesenchymal stem cell–derived small extracellular vesicles (sEVs) as a therapy for sepsis-related liver injury: evidence from a systematic review and meta-analysis. Frontiers in Pharmacology 2025; 16 doi: 10.3389/fphar.2025.1707784
|
